Wrap Technologies director granted 50K stock options
Wrap Technologies director Rajiv Srinivasan reported a new stock option grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Wrap Technologies director Rajiv Srinivasan reported a new stock option grant. On February 1, 2026, he received a stock option to buy 50,000 shares of Wrap Technologies common stock at an exercise price of $2.18 per share, expiring on February 1, 2036.
According to the filing, 16,500 options vested on the grant date, and the remaining options will vest ratably in three annual tranches thereafter, provided that he is employed or providing services to the company on each vesting date. After this grant, he beneficially owns 50,000 derivative securities directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 50,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. 16,500 of the stock options vested on the date of grant and the remainder will vest ratably in three annual tranches thereafter, provided that the Reporting Person is employed or providing services to the Issuer on the applicable vesting date
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did WRAP director Rajiv Srinivasan report?
How many Wrap Technologies (WRAP) options were granted to Rajiv Srinivasan?
What is the exercise price and term of Rajiv Srinivasan’s WRAP stock options?
How do the new WRAP stock options vest for director Rajiv Srinivasan?
Did the WRAP Form 4 filing report any stock sales by Rajiv Srinivasan?
Is Rajiv Srinivasan a director or officer of Wrap Technologies in this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.